The Cigna Group (NYSE:CI) Stock Holdings Increased by Aigen Investment Management LP

Aigen Investment Management LP raised its holdings in shares of The Cigna Group (NYSE:CI) by 147.1% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,883 shares of the health services provider’s stock after buying an additional 1,121 shares during the period. Aigen Investment Management LP’s holdings in The Cigna Group were worth $652,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Avantax Advisory Services Inc. grew its holdings in shares of The Cigna Group by 8.5% in the 1st quarter. Avantax Advisory Services Inc. now owns 3,612 shares of the health services provider’s stock worth $1,312,000 after acquiring an additional 284 shares during the last quarter. TD Asset Management Inc increased its stake in The Cigna Group by 13.8% in the 1st quarter. TD Asset Management Inc now owns 246,601 shares of the health services provider’s stock worth $89,563,000 after purchasing an additional 29,838 shares in the last quarter. Lord Abbett & CO. LLC raised its holdings in The Cigna Group by 43.9% during the 1st quarter. Lord Abbett & CO. LLC now owns 3,969 shares of the health services provider’s stock worth $1,441,000 after buying an additional 1,211 shares during the period. Banco BTG Pactual S.A. lifted its stake in The Cigna Group by 295.8% during the first quarter. Banco BTG Pactual S.A. now owns 4,908 shares of the health services provider’s stock valued at $1,783,000 after buying an additional 3,668 shares in the last quarter. Finally, GM Advisory Group LLC boosted its holdings in shares of The Cigna Group by 14.2% in the first quarter. GM Advisory Group LLC now owns 10,668 shares of the health services provider’s stock worth $3,875,000 after buying an additional 1,328 shares during the period. Institutional investors and hedge funds own 86.99% of the company’s stock.

The Cigna Group Price Performance

Shares of CI opened at $331.75 on Thursday. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.72 and a current ratio of 0.72. The firm has a market cap of $92.28 billion, a PE ratio of 31.30, a PEG ratio of 1.02 and a beta of 0.51. The firm’s 50 day moving average price is $340.84 and its 200 day moving average price is $340.08. The Cigna Group has a twelve month low of $253.95 and a twelve month high of $370.83.

The Cigna Group (NYSE:CI) last released its quarterly earnings results on Thursday, October 31st. The health services provider reported $7.51 earnings per share for the quarter, beating analysts’ consensus estimates of $7.22 by $0.29. The business had revenue of $63.70 billion for the quarter, compared to the consensus estimate of $59.58 billion. The Cigna Group had a net margin of 1.31% and a return on equity of 18.42%. The Cigna Group’s revenue for the quarter was up 29.8% on a year-over-year basis. During the same quarter last year, the firm earned $6.77 EPS. As a group, research analysts expect that The Cigna Group will post 28.5 EPS for the current fiscal year.

The Cigna Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, December 19th. Stockholders of record on Wednesday, December 4th will be paid a dividend of $1.40 per share. The ex-dividend date is Wednesday, December 4th. This represents a $5.60 annualized dividend and a dividend yield of 1.69%. The Cigna Group’s dividend payout ratio (DPR) is presently 52.83%.

Insider Activity

In other The Cigna Group news, Director William J. Delaney III sold 2,691 shares of the company’s stock in a transaction that occurred on Monday, August 19th. The stock was sold at an average price of $342.68, for a total transaction of $922,151.88. Following the completion of the sale, the director now owns 17,539 shares of the company’s stock, valued at $6,010,264.52. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.60% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several equities research analysts recently commented on the stock. Barclays upped their price target on shares of The Cigna Group from $405.00 to $420.00 and gave the company an “overweight” rating in a research report on Tuesday, November 5th. StockNews.com lowered The Cigna Group from a “strong-buy” rating to a “buy” rating in a report on Monday, November 4th. Deutsche Bank Aktiengesellschaft lowered their price target on The Cigna Group from $398.00 to $394.00 and set a “buy” rating on the stock in a report on Monday, November 4th. Cantor Fitzgerald reissued an “overweight” rating and issued a $400.00 price objective on shares of The Cigna Group in a research note on Wednesday, October 23rd. Finally, JPMorgan Chase & Co. lifted their target price on The Cigna Group from $435.00 to $438.00 and gave the company an “overweight” rating in a research note on Wednesday, August 21st. One investment analyst has rated the stock with a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Buy” and an average price target of $394.64.

The Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.